these subtle lines appear across the age spectrum
If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
Read more: Generic Zepbound: Why it doesnt exist yetand when it might Are generics always cheaper than brand-name drugs
Where it stands legally The medical version, afamelanotide (Scenesse), is FDA-approved for EPP
BPC 157 is a peptide that naturally occurs in the human stomach, specifically within a protein known as Body Protection Compound (BPC)
Total abstinence is rarely required by clinical guidance, but less alcohol in the first day or two reduces bruising risk and helps you notice any unusual symptoms